Search
Categories


Posts Tagged ‘Levitra’

Newly-Published Data Showed LEVITRA(R) Treated Erectile Dysfunction Effectively At First Dose In Men With Certain Associated Cardiovascular Conditions

Sunday, May 30th, 2010

LEVITRA(R) (vardenafil HCl), is effective at first dose with continued success in treating erectile dysfunction (ED) in men with associated me dical conditions that affect the cardiovascular system. These conditions included high blood pressure, diabetes and/or dyslipidemia, which includes high cholesterol and other lipid abnormalities. [click link for full article] (Source: Health News from Medical News Today)

Levitra® – Opportunity for Proactive Generic Companies?

Sunday, May 30th, 2010

The recently released GenericsWeb Pipeline Developer patent report for Levitra® (Vardenafil) highlights the importance of high quality patent information when considering development of generic equivalents in the early stages of a product's lifecycle. (PRWeb Mar 26, 2007)

Post Comment:Trackback URL: http://www.prweb.com/zingpr.php/UGlnZy1FbXB0LU1hZ24tRmFsdS1NYWduLVplcm8= (Source: PRWeb: Medical Pharmaceuticals)

New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) in Men with Dyslipidemia, Including High Cholesterol

Sunday, May 30th, 2010

The first prospective trial specifically designed to evaluate erectile function in ED patients with dyslipidemia

CHICAGO, Dec. 10 (HSMN NewsFeed) — Results of the first prospective trial specifically designed to evaluate erectile function in erectile… BiopharmaceuticalsSchering-Plough, erectile dysfunction, LEVITRA, vardenafil, dyslipidemia (Source: HSMN NewsFeed)

Cialis and Levitra Could Significantly Challenge Market Leader Viagra for Treatment of Erectile Dysfunction

Friday, May 28th, 2010

WALTHAM, Mass. – Decision Resources, Inc., one of the world’s leading research and advisory firms for pharmaceutical and health care issues, finds that a lthough the market for treating erectile dysfunction is dominated by Pfizer’s Viagra, the reported efficacy of Bayer/GlaxoSmithKline’s Levitra and the longer duration of action of Lilly/Icos’s Cialis… (Source: Drug Newswire)

MedWorm Message: Register for MedMatcha, MedWorm’s (more…)

Levitra for sphincter of Oddi dysfunction? Are you kidding?

Thursday, May 27th, 2010

In this month’s Gastrointestinal Endoscopy, an article by Cheon et al entitled, “Effects of vardenafil on sphincter of Oddi motility in patients with suspected biliary sphi ncter of Oddi dysfunction” outlines a case-controlled study that demonstrated a decrease in sphincter of Oddi pressures as measured with biliary manometry after the administration of vardenafil (Levitra; Bayer Healthcare Pharmaceuticals, Montville, NJ), a phosphodiesterase (more…)

Health Canada advises about vision problems possibly associated with Viagra, Cialis and Levitra

Thursday, May 27th, 2010

Health Canada is advising individuals who use the drugs Viagra, Cialis and Levitra to consult their physicians and seek immediate medical attention if they experience sudden vision loss or vision-related problems while taking these drugs. Viagra, Cialis and Levitra are drugs used to treat impotence and erectile dysfunction in men. The specific type of vision loss, called nonarteritic anterior ischemic optic neuropathy (NAION), occurs when blood (more…)

Warning label changes for Cialis, Levitra, and Viagra

Thursday, May 27th, 2010

The U.S. Food and Drug Administration has approved labeling changes for erectile dysfunction (ED) drugs in the class th at includes Cialis, Levitra, and Viagra, to display more prominently the potential risk of sudden hearing loss, and to guide consumers on what to do if they experience sudden problems with their hearing. (Source: News-Medical News Feed)

MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, (more…)

Newly-Published Data Showed LEVITRA(R) Treated Erectile Dysfunction Effectively At First Dose In Men With Certain Associated Cardiovascular Conditions

Wednesday, May 26th, 2010

LEVITRA(R) (vardenafil HCl), is effective at first dose with continued success in treating erectile dysfunction (ED) in men with associated medical conditions that affect the cardiovascular system. These conditions included high blood pressure, diabetes and/or dyslipidemia, which includes high cholesterol and other lipid abnormalities. [click link for full article] (Source: Erectile Dysfunction / Premature Ejaculation News From Medical News T (more…)

FDA Issues an Information for Healthcare Professionals Sheet for Viagra, Levitra, and Cialis

Wednesday, May 26th, 2010

Information for Healthcare Professionals
Sildenafil (marketed as Viagra and Revatio) Vardenafil (marketed as
Levitra) Tadalafil ( marketed as Cialis)
ROCKVILLE, Md., Nov. 14, 2007–FDA SUMMARY [11/2007]:
FDA has received reports of cases of… (Source: Drugs.com – Pharma News)

MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.

Levitra May Protect The Heart, VCU Study Shows

Sunday, May 23rd, 2010

The widely used erectile dysfunction drug Levitra is now the second drug in its class found to protect the heart against tissue damage following acute heart attack, according to a new study by Virginia Commonwealth University researchers. [click link for full article] (Source: Erectile Dysfunction / Premature Ejaculation News From Med ical News Today)

Page 1 of 41234